CRISPR Therapeutics
CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform.

Year Established: 2013
Stock Ticker: CRSP
Exchange: NASDAQ